Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CBAY

CymaBay Therapeutics (CBAY) Stock Price, News & Analysis

CymaBay Therapeutics logo

About CymaBay Therapeutics Stock (NASDAQ:CBAY)

Advanced Chart

Key Stats

Today's Range
$32.48
$32.48
50-Day Range
$32.18
$32.48
52-Week Range
$7.26
$32.50
Volume
73 shs
Average Volume
4.11 million shs
Market Capitalization
$3.73 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CBAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CymaBay Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CBAY Stock News Headlines

Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Gilead Sciences Completes Acquisition Of CymaBay Therapeutics
CBAY Jul 2024 34.000 call
CBAY Apr 2024 31.000 put
CBAY Oct 2024 33.000 call
See More Headlines

CBAY Stock Analysis - Frequently Asked Questions

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) announced its earnings results on Wednesday, February, 28th. The biopharmaceutical company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.31) by $0.04. The biopharmaceutical company earned $0.06 million during the quarter, compared to analysts' expectations of $0.42 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that CymaBay Therapeutics investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Jabil (JBL), Adobe (ADBE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
2/28/2024
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CBAY
CIK
1042074
Employees
101
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$105.37 million
Net Margins
N/A
Pretax Margin
-339.11%
Return on Equity
-50.72%
Return on Assets
-31.04%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.96
Quick Ratio
10.96

Sales & Book Value

Annual Sales
$31.07 million
Price / Sales
119.92
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.58 per share
Price / Book
12.59

Miscellaneous

Outstanding Shares
114,724,000
Free Float
106,693,000
Market Cap
$3.73 billion
Optionable
Optionable
Beta
0.32

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:CBAY) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners